Table I.
Clinicopathological characteristic | No. of cases (%) |
---|---|
Age, years | |
≤3 | 5 (8.6) |
>3 | 53 (91.4) |
Sex | |
Male | 46 (79.3) |
Female | 12 (20.7) |
WHO histological subtype | |
Classic | 44 (75.9) |
Desmoplastic | 14 (24.1) |
Residual tumor size, cm2 | |
<1.5 | 44 (75.9) |
≥1.5 | 14 (24.1) |
Metastatic status | |
M0 | 25 (43.1) |
M1 | 33 (56.9) |
Tumor risk | |
Standard | 17 (29.3) |
High | 41 (70.7) |
Differentiation level | |
Undifferentiated | 19 (32.8) |
Differentiated | 39 (67.2) |
Expression of SPOPL | |
Negative | 2 (3.4) |
Positive | 56 (96.6) |
Low | 42 (75) |
High | 14 (25) |
WHO, World Health Organization; SPOPL, Speckle-type POZ protein-like.